ecrin-mdr-crcClinical2022colorectal cancerColorectal CancerInterventionalhttps://newmdr.ecrin.org/Study/40030China5ECRIN MDRNot yet recruitingfalseEfficacy and safety of combination of fluoroquinolone and trifluridine in patients with MMS advanced colorectal cancer after failure of second-line therapyInterventions: Treatment group:Fluoroquinolone combined with trifluridine tipiracil Primary outcome(s): Progression-free survival;Disease control rate Study Design: Cross-sectional2022-05-1540030ChiCTR2200059983